State Ledger
Company profile

Unicycive Therapeutics, Inc. CIK 1766140

Ticker
UNCY (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Mountain View, CA 94040
Fiscal year end
2025 (FY)
Market Data
Close
$4.11
Change
+$0.06
Change %
1.48%
Volume
39,668

UNCY · trading date Oct 9, 2026 · previous close $4.05 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$26.56M
Total assets
$49.14M
Total liabilities
$18.94M
Stockholders' equity
$30.20M
Cash & equivalents
$29.20M
Operating income
-$29.52M
Operating cash flow
-$31.32M
Capital expenditures
$24.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$31.34M
Free cash flow margin
—
Liabilities / assets
38.5%
Equity / assets
61.5%
CapEx / revenue
—
Operating cash flow / net income
1.18×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$26.56M $49.14M $18.94M $30.20M
2024 — -$36.73M $31.67M $24.24M $7.43M
2023 $675.0K -$30.54M $14.19M $18.00M -$3.81M
2022 $951.0K -$18.06M $2.82M $3.28M -$466.0K
2021 — -$10.02M $18.74M $2.26M $16.48M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G/A
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Mountain View, CA 94040
1975 W. EL CAMINO REAL, SUITE 204
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies